Related Experiment Video
Updated: May 1, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Immunopathogenesis of membranous nephropathy: an update
1Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1155, 75005, Paris, France, hanna.debiec@upmc.fr.
Abstract:
Membranous nephropathy (MN) is a non-inflammatory organ-specific autoimmune disease which affects the kidney glomerulus, resulting in the formation of immune deposits on the outer aspect of the glomerular basement membrane, complement-mediated proteinuria, and severe renal failure in 30% of patients. In the last 10 years, substantial advances have been made in the understanding of the molecular bases of MN, with the identification of several antigens and predisposing genes in children and adults. These ground-breaking findings already have a major impact on diagnosis and monitoring and to some extent on therapies. However, there is evidence that the disease is more complex and involves a variety of antigen-antibody systems and genes involved in immune response, progression, recovery, and protective mechanisms. We herein review these recent findings which open new perspectives of research. Understanding the complex pathogenesis of MN will offer many opportunities for future therapeutic interventions and will hopefully have a major impact on patient care. New insights into the molecular mechanisms of MN may also enlighten the pathogenesis of organ-specific autoimmune diseases.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Encephalitis ll: Pathophysiology
Diabetic Nephropathy
Myasthenia Gravis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Cytomegalovirus Disease

